Risk factors for locoregional relapse after radical nephrectomy.

about

Risk factors for locoregional relapse after radical nephrectomy.

Item

http://www.wikidata.org/entity/Q48166055

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Risk factors for locoregional relapse after radical nephrectomy.

@en

Risk factors for locoregional relapse after radical nephrectomy.

@nl

type

Item

label

Risk factors for locoregional relapse after radical nephrectomy.

@en

Risk factors for locoregional relapse after radical nephrectomy.

@nl

prefLabel

Risk factors for locoregional relapse after radical nephrectomy.

@en

Risk factors for locoregional relapse after radical nephrectomy.

@nl

P1476

Risk factors for locoregional relapse after radical nephrectomy

@en

P2093

Gregory Swanson

http://www.w3.org/2001/XMLSchema#string

Jessica Pruszynski

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials.

Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.

Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: results of a phase III randomised European Organisation for Research and Treatment of Ca

Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines

Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.

Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.

Adjuvant therapy in renal cell carcinoma-past, present, and future.

Treatment of localised renal cell carcinoma.

Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.

P304

192-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12684

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sameer Jhavar

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28488392

http://www.w3.org/2001/XMLSchema#string